Skip to main content
Equibles
WELL logo

WELL · Welltower Inc. · Metrics

Track WELL — free

Use WELL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research WELL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$225.64 -1.08 (-0.48%) Q3 2026 earnings call transcript
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$159.57B
Shares
733.61M
Volume · Oct 28 2.55M Avg daily vol (3M) 2.79M

WELL metrics

89 of 126 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$226.72
Market cap
$159.57B

Price action

20 metrics
Price change (1W)
-4.8%
Price change (30D)
-2.7%
Price change (3M)
-6.9%
Price change (6M)
+5.8%
Price change (YTD)
+22.1%
Price change (1Y)
+24.2%
Trailing year
Price change (5Y)
+175.5%
52-week high
$252.07
52-week low
$176.96
Change from 52-week high
-10.1%
Change from 52-week low
+28.1%
Annualized volatility
23.3%
Annualized volatility (3M)
22.3%
Beta
-0.1
RSI (14D)
42.8
Price vs SMA 50
-3.0%
Price vs SMA 200
+4.1%
Avg volume (3M)
2.79M
Relative volume
2.2
Average dollar volume
$652.04M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
733.61M

Valuation

14 metrics
P / FFO
61.1×
Company-stated · TTM · reciprocal yield 1.6%
P / AFFO
—
P / E (TTM)
98.6
Trailing earnings · reciprocal yield 1.0%
PEG ratio
3.1
EV / revenue
12.7×
reciprocal yield 7.9%
EV / EBITDA
—
EV / EBIT
—
P / sales
11.6×
reciprocal yield 8.6%
P / book
3.3
reciprocal yield 30.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
47.9
reciprocal yield 2.1%
Earnings yield
1.1%

Historical valuation

8 metrics
P / E historical average (3Y)
118.0×
reciprocal yield 0.8%
P / E historical average (5Y)
146.7×
reciprocal yield 0.7%
EV / revenue historical average (3Y)
12.5×
reciprocal yield 8.0%
EV / revenue historical average (5Y)
11.4×
reciprocal yield 8.8%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
1.4%
Trailing 12 months
Payout ratio
124.1%
Shareholder yield
1.4%
Dividend / share (TTM)
$3.07
Dividend growth YoY
+11.6%
Dividend growth streak
2
Last ex-dividend
2026-08-12

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-27

Profitability

9 metrics
Gross margin
39.2%
Operating margin
—
Trailing 12 months
Net margin
12.7%
Gross profit (TTM)
$5.41B
Operating profit (TTM)
—
Net income (TTM)
$1.75B
Trailing 12 months
Diluted EPS (TTM)
$2.30
FCF margin
—
Effective tax rate
—

Per share

13 metrics
FFO per diluted share
—
AFFO per diluted share
—
Revenue per diluted share (TTM)
$18.82
Gross profit per diluted share (TTM)
$7.38
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$2.38
Operating cash flow per diluted share (TTM)
$4.53
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$2.20
Book value per share
$66.37

Growth

11 metrics
Revenue growth YoY
+38.4%
Year over year
Net income growth YoY
+47.0%
Revenue (TTM)
$13.79B
Trailing 12 months
EPS growth YoY
+31.7%
Shares change YoY
+10.1%
Year over year · more shares
Revenue CAGR (3Y)
+22.7%
Revenue CAGR (5Y)
+18.7%
EPS CAGR (3Y)
+66.7%
EPS CAGR (5Y)
-9.8%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
3.6%
Return on assets
2.4%
Debt / equity
0.4
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$15.88B
Latest balance sheet
Cash & equivalents
$2.27B
Total assets
$73.71B
Total debt
$18.15B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$3.33B
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
$1.76B
Stock compensation (TTM)
$1.57B
R&D / revenue
—
Stock compensation / revenue
11.4%

Ownership (13F)

9 metrics
13F filers
1,617
13F filer change QoQ
+108
Institutional ownership
97.5%
Conviction holders (share of 13F filers)
2.2%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+1.4%
Holder tenure
17.6
Price vs estimated holder cost
+63.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
21.8%

Short interest

3 metrics
Short interest
2.3%
Latest settlement · 6.2 days to cover
Days to cover
6.2d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
$2.41M
Insider-sentiment score
81 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 766704 CUSIP 95040Q104 13F (30d) 530 filings 507 filers Visit website Investor relations